Although an increment of the UV lethality has been observed when augmenting the temperature, the different behavior of E. coli, Salmonella Typhimurium, L. monocytogenes, and S. aureus in response to UV-H treatments in relation to the treatment temperature makes it difficult to compare data.
On the other hand, local lethality has an affect on the FDA approval and clinical trial-based drug sharing, but not on the number of FDA approved drugs and clinical drug trials.
The correlation and linear regression analyses suggest that global lethality has an impact on the drug trial and approval numbers, for the cancers in this study.
In part, the promise of synthetic lethality has been borne out by the successful translation of the sensitivity of tumours deficient in BRCA1 or BRCA2 to treatment with poly (ADP-ribose) polymerase (PARP) inhibitors (Tutt et al, 2010; Ashworth et al, 2011).
We suggest that this role is independent of the sex determination process as no sex-specific lethality has been observed and the other components (fem and csd) regulating sex determination produce no lethal phenotype (Beye et al. 2003; Hasselmann et al. 2008; Gempe et al. 2009).
But its lethality has been used in the past to bring devastation to civilian neighborhoods, most famously by the Russians during the siege of the Chechen capital of Grozny over a decade ago, where thousands of civilians were killed and hundreds of buildings reduced to rubble.
Our analyses suggest that global lethality has an affect on the number of FDA approved and clinical trial cancer drugs.
We showed that local lethality has an effect on the clinical cancer drug trial sharing as well as FDA approved drug sharing, the latter appears to be a recent trend.
Recently, significant work in the area of synthetic lethality has led to new approaches for the treatment of BRCA1/2-deficient cancers using high efficacy poly(ADP-ribose) polymerase 1 (PARP1) inhibitors (PARPi) with high efficiency [ 20- 24].
This embryonic lethality has an effect of derepression of the transcription repressor complex c-myc-Miz1.
